WINKAST-SF 250 LIFE CAPS
PULMOLIFE
Top

WINKAST-SF 250 LIFE CAPS

MRP: 330

Packaging: 30

Pack Type: life-caps

Composition:

Salmeterol 50mcg + Fluticasone 250mcg

Indication:

Asthma, COPD

Description:

Salmeterol 50 mcg + Fluticasone Propionate 250 mcg is a fixed-dose combination inhaler that provides dual action for the long-term control of asthma and chronic obstructive pulmonary disease (COPD). Salmeterol, a long-acting beta-2 agonist (LABA), relaxes the airway muscles to improve airflow, while Fluticasone, an inhaled corticosteroid (ICS), reduces inflammation in the airways. Together, they help decrease symptoms, prevent exacerbations, and improve pulmonary function in chronic respiratory conditions.

Tags:

Asthma Management COPD Treatment ICS + LABA Inhaler Respiratory Health Inhalation Therapy
  • Dual-action control of inflammation and bronchospasm
  • Improves lung function and reduces exacerbations
  • Ideal for long-term asthma and COPD management
  • Reduces need for rescue medication over time
  • Enhances daytime and nighttime symptom control

Usage Information

Dosage

Standard adult dose: 1 inhalation twice daily Administration route: Oral inhalation via DPI or MDI Instructions: Shake well (if MDI) before use Rinse mouth after inhalation Follow correct inhaler technique for effectiveness

Side Effects

Oral thrush (fungal infection) Hoarseness or sore throat Headache Increased heart rate Tremors Muscle cramps Rare: Hypokalemia, adrenal suppression, allergic reactions

Contraindications

Hypersensitivity to Fluticasone, Salmeterol, or formulation excipients Not indicated for acute bronchospasm or asthma attack Use cautiously in: Cardiovascular disorders Diabetes Thyroid dysfunction Pulmonary infections (TB, fungal, or viral)

WINKAST-SF 250 LIFE CAPS - PULMOLIFE | Intralife Pharmaceuticals | Intralife